|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss for the year | |||||
| Depreciation and amortization | |||||
| Share based compensation | |||||
| Revaluation of liability in respect to warrants and pre-funded warrants | |||||
| Day 1 loss from issuance of financial instruments | |||||
| Financing expenses (income), net | |||||
| Decrease (increase) in other receivables | |||||
| Increase (decrease) in trade payables | |||||
| Increase in other payables | |||||
| Interest received | |||||
| Purchase of property, plant and equipment | |||||
| Redemption of (investment in) short term deposit | |||||
| Investment in restricted deposit, net | |||||
| Exercise of warrants and options | |||||
| Repayment of lease liability | |||||
| Issuance of shares, warrants and pre-funded warrants, net | |||||
| Share based payment modification | |||||
| Exercise of warrants and pre-funded warrants | |||||
| Cash flows from operating activities | |||||
| Net loss for the year | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Share based compensation | |||||
| Revaluation of liability with respect to warrants | |||||
| Financing expenses, net | |||||
| Changes in assets and liabilities: | |||||
| Decrease in operating right of use asset | |||||
| Decrease in operating lease liability | |||||
| Decrease (increase) in other current assets | |||||
| Increase (decrease) in trade payables | |||||
| Increase in other payables | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Redemption of (investment in) short-term deposits | |||||
| Redemption of (investment in) restricted deposit, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Exercise of warrants and options | |||||
| Issuance costs | |||||
| Net cash provided by financing activities | |||||
| Effects of exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents as of the beginning of the year | |||||
| Cash and cash equivalents as of the end of the year | |||||
| Non-cash investing and financing activities: | |||||
| Reclassification of warrants into equity | |||||
| Bonus accrual reclassification to equity (See Note 14) | |||||
| Bonus accrual reclassification to equity (See Note 13) | |||||
| Conversion of liability into shares | |||||
| Recognition of right of use assets | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest received | |||||
Loading...